Evidence map›Paper›PMID 36722312›Full record

ArticleCell proliferation2023

The m6A reader YTHDC1 regulates muscle stem cell proliferation via PI4K-Akt-mTOR signalling.

Jin Liu, Hongna Zuo, Ziliu Wang, Wei Wang, Xuezhen Qian, Yingyuan Xie, Di Peng, Yubin Xie, Liquan Hong, Wanling You and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cell proliferation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. The role of mNaunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. YTHDC1-Mediated mJournal of agricultural and food chemistry · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Periplakin Attenuates Liver Fibrosis via Reprogramming CD44Cellular and molecular gastroenterology and hepatology · 2025
    Article
  11. Article
  12. Article
  13. NCells · 2024
    Article
  14. Article
  15. Epigenetic control of skeletal muscle atrophy.Cellular & molecular biology letters · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. The Biological Role of LRPPRC in Human Cancers.Cancer control : journal of the Moffitt Cancer Center
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Jin LiuKey Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Jinan University, Guangzhou, China.
Hongna ZuoKey Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Jinan University, Guangzhou, China.
Ziliu WangKey Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Jinan University, Guangzhou, China.
Wei WangKey Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Jinan University, Guangzhou, China.
Xuezhen QianState Key Laboratory of Reproductive Medicine, Gusu School, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, Nanjing, China.
Yingyuan XieMOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
Di PengState Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
Yubin XieState Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
Liquan HongDepartment of Clinical Laboratory, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
Wanling YouKey Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Jinan University, Guangzhou, China.
Huiling LouDepartment of Geriatrics, National Key Clinical Specialty, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Guanzheng LuoMOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
Jian RenState Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
Bin ShenState Key Laboratory of Reproductive Medicine, Gusu School, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0002-8946-8448
Jinping ZhengDepartment of Public Health and Preventive Medicine, Changzhi Medical College, Changzhi, P. R. China.
Hu WangKey Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Jinan University, Guangzhou, China.
Zhenyu JuKey Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Jinan University, Guangzhou, China.
Jinan University · CNSun Yat-sen University · CNNanjing Maternity and Child Health Care Hospital · CNAffiliated Hospital of Hangzhou Normal University · CNChangzhi Medical College · CNGuangzhou First People's Hospital · CN

Funding

National Key R&D Program of China 2018YFA0109300National Key R&D Program of China 2021YFA1100103National Key R&D Program of China 2021YFA1102800National Natural Science Foundation of China 31970796National Natural Science Foundation of China 82022026National Natural Science Foundation of China 82030039National Natural Science Foundation of China 82230047National Natural Science Foundation of China 92049304Program for Guangdong Introducing Innovative and Entrepreneurial Teams 2017ZT07S347Science and Technology Projects in Guangzhou 202102010070Science Foundation for Distinguished Young Scholars of Guangdong Province 2019B151502008the Open Project of the State Key Laboratory of Trauma, Burn and Combined Injury, Third Military Medical University SKLKF202002Zhejiang medical and health science and technology plan project 2018KY590
6 · The paper itself

Abstract

Muscle stem cells are required for the homeostasis and regeneration of mammalian skeletal muscles. It has been reported that RNA N6-methyladenosine (m6A) modifications play a pivotal role in muscle development and regeneration. Nevertheless, we know little about which m6A reader regulates mammalian muscle stem cells. Here, we discovered that the m6A reader Ythdc1 is indispensable for mouse skeletal muscle regeneration and proliferation of muscle stem cells. In the absence of Ythdc1, Muscle stem cells in adult mice are unable to exit from quiescence. Mechanistically, Ythdc1 binds to m6A-modified Pi4k2a and Pi4kb mRNAs to regulate their alternative splicing and thus PI4K-Akt-mTOR signalling. Ythdc1-null muscle stem cells show a deficiency in phosphatidylinositol (PI) 3,4,5-trisphosphate, phospho-Akt and phospho-S6, which correlates with a failure in exit from quiescence. Our findings connect dynamic RNA methylation to the regulation of PI4K-Akt-mTOR signalling during stem cell proliferation and adult tissue regeneration.

Indexed as

Proto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesAnimalsCell ProliferationMammalsMiceMusclesRNA, MessengerProto-Oncogene Proteins c-aktRNA, MessengerTOR Serine-Threonine Kinases

Identifiers

PMID36722312
PMCPMC10392063
OpenAlexW4318754750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.